Retatrutide (also identified by the compound code LY3437943) is an investigational peptide medicine being developed by Eli Lilly as a potential treatment for obesity and related metabolic conditions
Molecular Therapy / PMC (2017) 7
Julie-Ann Lloyd, Amin Andalib, Alice Race, Holly Ann Burt, Farah Husain, Matthew Goldblatt, Matthew Kroh Surgical Endoscopy.2023
Weight loss of 2-5 pounds over 4-8 weeks appears in some reviews, though these users also typically mention dietary changes and exercise alongside supplement use
BPC-157 promotes healing by: It is particularly well-studied for tendon-to-bone healing, making it popular among athletes and orthopedic patients
Own manufacturing We produce our products and sell them directly to you